International Journal of Radiation Oncology Biology Physics Volume 109 Issue 1 to 5

Journal Spotlight: International Journal of Radiation Oncology – Biology – Physics (IJROBP)

The International Journal of Radiation Oncology – Biology – Physics (IJROBP), affectionately known as the Red Journal, stands as a premier publication in the field of radiation oncology. Here are the key highlights and focus areas of this influential journal:

Interdisciplinary Scope: The Red Journal covers a wide spectrum of subjects within radiation oncology, radiation biology, medical physics, and aspects related to education and health policy. Its interdisciplinary approach fosters collaboration and knowledge exchange across these critical domains.

Original Investigations: IJROBP places a particular emphasis on original contributions, including prospective clinical trials, outcomes research, and large database analysis. These contributions serve to advance the understanding and practice of radiation oncology.

Innovations and Advances: The journal seeks reports on high-impact innovations in various facets of radiation treatment, including single or combined modalities, tumor sensitization, and normal tissue protection. This encompasses precision avoidance techniques and pharmacological approaches. Advances in areas such as brachytherapy, particle irradiation, and cancer imaging are also welcomed.

Technical Advances: Technical advancements related to dosimetry and radiation treatment planning are of significant interest. These innovations contribute to the precision and effectiveness of radiation therapy, ultimately benefiting patient care.

Exploration of Tumor Physiology: IJROBP features basic science studies that delve into tumor physiology and the molecular biology underpinning cancer and the normal tissue response to radiation. This focus on the fundamental aspects of radiation oncology informs clinical practice and innovation.

Sister Publications: The Red Journal is complemented by sister publications, including Practical Radiation Oncology and Advances in Radiation Oncology. These publications collectively provide a comprehensive platform for disseminating research and insights in the field.

The journal is committed to maintaining the highest ethical and medical standards. It provides a valuable space for researchers, clinicians, and professionals in the field of radiation oncology to share their findings, innovations, and perspectives. The Red Journal plays a pivotal role in advancing the practice of radiation therapy and improving patient outcomes.

Please note that the views expressed in IJROBP are those of the individual authors and not necessarily those of the American Society for Radiation Oncology (ASTRO) or the Publisher. The journal’s content is not a substitute for medical advice, and no responsibility is assumed for any consequences arising from its use.

Moreover, while advertising material is expected to adhere to ethical medical standards, its inclusion in the publication does not constitute an endorsement of the advertised products or services.

For more information about IJROBP, its submissions, and guidelines, please refer to the journal’s official website.

Volume 109, Issue 1: Pages A1-A16, 1-308 (1 January 2021)

Volume 109, Issue 2: Pages A1-A18, 305-646 (1 February 2021)

Volume 109, Issue 3: Pages A1-A12, 647-838 (1 March 2021)

Volume 109, Issue 4: Pages A1-A12, 839-1130 (15 March 2021)

Volume 109, Issue 5: Pages A1-A12, 1131-1662 (1 April 2021)